The quinoxaline derivative caroverine in the treatment of sensorineural smell disorders: A proof-of-concept study

Acta Oto-Laryngologica

Volumn 122, Issue 8, 2002, Pages 877-881

  Quint, Christian ^a   Temmel, Andreas F P ^a   Hummel, Thomas ^b   Ehrenberger, Klaus ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF DRESDEN MEDICAL SCHOOL   (Germany)

Author keywords

Anosmia; Caroverine; Hyposmia; Olfaction; Therapy

Indexed keywords

BUTANOL; CAROVERINE; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; QUINOXALINE DERIVATIVE; ZINC SULFATE;

ADULT; AGED; ANOSMIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE FEEDBACK; ODOR; OLFACTORY SYSTEM; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORINEURAL SMELLING DISORDER; SINGLE BLIND PROCEDURE; SMELLING DISORDER; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; N-METHYLASPARTATE; OLFACTION DISORDERS; QUINOXALINES; SENSORY THRESHOLDS; SMELL; ZINC SULFATE;

EID: 0036965784     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655402/000028054     Document Type: Article

References (28)

1. Hoffman HJ, Ishii EK, MacTurk RH. Age-related changes in the prevalence of smell/taste problems among the United States adult population. Results of the 1994 disability supplement to the National Health Interview Survey (NHIS). Ann N Y Acad Sci 1998; 855: 716-22.
2. Quint C, Temmel AF, Schickinger B, Pabinger S, Ramberger P, Hummel T. Patterns of non-conductive olfactory disorders in eastern Austria: a study of 120 patients from the Department of Otorhinolaryngology at the University of Vienna. Wien Klin Wochenschr 2001; 113: 52-7.
3. Duncan HJ, Smith DV. Clinical disorders of olfaction. A review. In: Doty RL, ed. Handbook of olfaction and gustation. New York: Marcel Dekker, 1995: 345.
4. Temmel AFP, Quint C, Schickinger-Fischer B, Klimek L, Stoller E, Hummel T. Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg 2002; 128; 635-41.
5. Selden AM. Olfactory loss secondary to nasal and sinus pathology. In: Selden AM, ed. Taste and smell disorders. New York: Thieme, 1997: 52-71.
6. Ehrenberger K, Felix D. Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: a survey. Acta Otolaryngol (Stockh) 1995; 115: 236-40.
7. Schoppa NE, Kinzie JM, Sahara Y, Segerson TP, Westbrook GL. Dendrodendritic inhibition in the olfactory bulb is driven by NMDA receptors. J Neurosci 1998; 18: 6790-802.
8. Ehrenberger K, Felix D. Caroverine depresses the activity of cochlear glutamate receptors in guinea pigs: in vivo model for drug-induced neuroprotection. Neuropharmacology 1992; 31: 1259-63.
9. Pujol R, Puel JL. Excitotoxicity, synaptic repair, and functional recovery in the mammalian cochlea: a review of recent findings. Ann N Y Acad Sci 1999; 884: 249-54.
10. Henkin RI, Schlechter PJ, Friedewald WT, Demets DL, Raff M. A double blind study of the effects of zinc sulfate on taste and smell dysfunction. Am J Med Sci 1976; 272: 285-99.
11. Seiden AM. The initial assessment of patients with taste and smell disorders. In: Seiden AM, ed. Taste and smell disorders. New York: Thieme, 1997: 4-19.
12. Hummel T, Sekinger B, Wolf SR, Pauli E, Kobal G. "Sniffin' Sticks": olfactory performance assessed by the combined testing of odor identification, odor discrimination, and olfactory thresholds: Chem Senses 1997; 22: 39-52.
13. Kobal G, Hummel T, Sekinger B, Barz S, Roscher S, Wolf SR. "Sniffin' Sticks": screening of olfactory performance. Rhinology 1996; 34: 222-6.
14. Ehrenstein WH, Ehrenstein A. Psychophysical methods. In: Windhorst U, Johansson H, eds. Modern techniques in neuroscience research. Berlin: Springer, 1999: 1211-41.
15. Kobal G, Klimek L, Wolfensberger M, et al. Multicenter investigafign of 1,036 subjects using a standardized method for the assessment of olfactory function combining tests of odor identification, odor discrimination, and olfactory thresholds. Eur Arch Otorhinolaryngol 2000; 257: 205-11.
16. Aroniadou-Anderjaska V, Ennis M, Shipley MT. Dendrodendritic recurrent excitation in mitral cells of the rat olfactory bulb. J Neurophysiol 1999; 82: 489-94.
17. Oestreicher E, Arnold W, Ehrenberger K, Felix D. New approaches for inner ear therapy with glutamate antagonists. Acta Otolaryngol (Stockh) 1999; 119: 174-8.
18. Mangano DT, Mangano CM. Perioperative stroke, encephalopathy, and central nervous system dysfunction. J Int Care Med 1997; 12: 148-60.
19. Bredt DS, Snyder SH. Nitric oxide mediates glutamate-linked enhancement of cgmp levels in the cerebellum. Proc Natl Acad Sci USA 1989; 86: 9030-3.
20. Lubec B, Hayn M, Denk W, Bauer G. Brain lipid peroxidation and hydroxy radical attack following the intravenous infusion of hydrogen peroxide in an infant. Free Radic Biol Med 1996; 21: 219-23.
21. Rothman SM, Olney JW. Excitotoxicity and the NMDA receptor - still lethal after eight years. Trends Neurosci 1995; 18: 57-8.
22. Fagg GE, Foster AC. Amino acid neurotransmitters and their pathways in the mammalian central nervous system. Neuroscience 1983; 9: 701-19.
23. Drian MJ, Kamenka JM, Pirat JL, Privat A. Non-competitive antagonists of N-methyl-D-aspartate prevent spontaneous neuronal death in primary cultures of embryonic rat cortex. J Neurosci Res 1991; 29: 133-8.
24. Mosinger JL, Price MT, Bai HY, Xiao H, Wozniak DF, Olney JW. Blockade of both NMDA and non-NMDA receptors is required for optimal protection against ischemic neuronal degeneration in the in vivo adult mammalian retina. Exp Neurol 1991; 113: 10-7.
25. Tremblay R, Chakravarthy B, Hewitt K, et al. Transient NMDA receptor inactivation provides long-term protection to cultured cortical neurons from a variety of death signals. J Neurosci 2000; 20: 7183-92.
26. Barnett HJM, Eliasziw M, Meldrum HE. Drugs and surgery in the prevention of ischemic stroke. N Engl J Med 1995; 332: 238-48.
27. Cassirer AM. The missing zinc. J Am Med Womens Assoc 1981; 36: 269.
28. Aiba T, Sugiura M, Mori J, et al. Effect of zinc sulfate on sensorineural olfactory disorder. Acta Otolaryngol Suppl (Stockh) 1998; 538: 202-4.